This inventor holds 1 USPTO granted patent. Top assignee: Karolinska Innovations Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Johan Carlson: Innovator in Malaria Research
Introduction
Johan Carlson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of malaria research through his innovative work on polypeptides. His research focuses on developing carbohydrates that can act as receptors for malaria antigens, which is crucial for advancing treatment options.
Latest Patents
Carlson holds a patent for "Malaria polypeptides." This invention relates to carbohydrates capable of acting as receptors for malaria antigens present on the surfaces of malaria-infected erythrocytes. The receptors he developed comprise negatively charged glycosaminoglycan-like moieties, preferably sulphated. Additionally, the invention includes novel malaria polypeptides that can act as ligands in relation to these receptors. The patent also encompasses the use of these polypeptides as medicaments and pharmaceutical compositions, as well as antibodies directed against the new ligands. He has 1 patent to his name.
Career Highlights
Carlson is associated with Karolinska Innovations AB, where he continues to push the boundaries of malaria research. His work is instrumental in the development of new therapeutic strategies against malaria, a disease that affects millions worldwide.
Collaborations
Some of his notable coworkers include Mats Wahlgren and Chen Qijun, who have collaborated with him on various research projects aimed at combating malaria.
Conclusion
Johan Carlson's innovative contributions to malaria research highlight the importance of scientific advancements in addressing global health challenges. His work on malaria polypeptides represents a significant step forward in the fight against this devastating disease.